FOLH1 and neoplasm: Tissue staining with three different anti-PSMA antibodies showed heterogeneous results, with one antibody negative for all three tumor cell lines (ab58779, Abcam), one positive in all three (NBP1-45057, Novus), and one split (NBP1-89822, Novus).